Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
4 NC counties are under alert, including Edgecombe County.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novartis Ag ADR
(NY:
NVS
)
110.32
+0.39 (+0.35%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
28
29
Next >
Novartis' Ligelizumab Suffers Setback In Late-Stage Skin Disorder Studies
December 20, 2021
Novartis AG (NYSE: NVS) said that its ligelizumab antibody treatment against recurring hives did not meet the goal of superiority to standard treatment Xolair (...
Via
Benzinga
The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More
December 17, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of December 13, 2021.
Via
Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Calliditas Gets Conditional Approval For Kidney Inflammation Disease Drug...
Via
Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
December 16, 2021
Novartis AG (NYSE: NVS) is launching a new share buyback worth up to $15 billion to be executed by the end of 2023, adding it was confident in its top-line growth...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
December 15, 2021
We're at the halfway point of the week but there's no slowing down as we dive into the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
Molecular Partners Inks License Deal With Novartis For $580M
December 14, 2021
Molecular Partners AG (NASDAQ: MOLN) entered into a license agreement with Novartis AG (NYSE: NVS) to develop, manufacture, and commercialize DARPin-...
Via
Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
December 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Vaccitech To Buy Avidea For $40M Vaccitech plc (NASDAQ: VACC) announced that...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
December 14, 2021
Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
The two publicly-traded companies confirmed Monday that they have signed a definitive agreement under which Pfizer will acquire all outstanding shares of Arena for $100 per share in an all-cash...
Via
Talk Markets
Topics
Cannabis
Exposures
Cannabis
How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal
December 13, 2021
Pharmaceutical giant Pfizer Inc. (NYSE:PFE) is e...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
7 CEOs That Ought to Follow Jack Dorsey Out the Door
December 10, 2021
Jack Dorsey stepped down as Twitter CEO despite stock gains, but not every CEO can say the same. Here are seven CEOs who need to go.
Via
InvestorPlace
Omicron Surge
December 09, 2021
The seemingly good level of joblessness at a mere 184,000 turns out to be less wonderful than it appears, at the lowest since 1969.
Via
Talk Markets
Novartis Reveals Two Year Results From Beovu Trial In Diabetic Macular Edema Patients
December 09, 2021
Novartis AG (NYSE: NVS) has reported the first interpretable results from year two (week 100) of the Phase 3 KESTREL study of Beovu (brolucizumab) 6 mg in patients...
Via
Benzinga
Novartis' New Kisqali Data Shows Consistent Overall Survival Benefit Across Metastatic Breast Cancer Settings
December 08, 2021
Novartis AG (NYSE: NVS) shared new data from the MONALEESA Phase 3 program of Kisqali (ribociclib), the CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer and...
Via
Benzinga
Thursday Markets Overview
December 02, 2021
Today we are seeing an across-the-board rise in stock prices on hopes for lower inflation and Omicron jabbing.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
Upgrades According to TD Securities, the prior rating for MAG Silver Corp (AMEX:
Via
Benzinga
Aurinia Pharma Surges Again As Novartis Joins List Of Potential Suitors
December 02, 2021
Aurinia Pharma popped after Novartis said it's focused on bolt-on deals.
Via
Investor's Business Daily
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative...
Via
Benzinga
Exposures
Product Safety
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
December 02, 2021
Gene therapy startup Dyno Therapeutics Inc has partnered with pharmaceutical giants such as Novartis AG (NYSE: NVS) and Roche Holdings AG (OTC: RHHBY...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021
December 03, 2021
Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ:
Via
Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
Aurinia Pharma (AUPH) stock is on the rise Thursday as investors hold out hope for a takeover of the company by Novartis (NVS).
Via
InvestorPlace
Breakthrough Cancer Therapy? This Biotech Shares Preclinical Data and Ambitious Plans
December 02, 2021
Photo by National Cancer Institute on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a...
Via
Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
December 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus U.K. Signs Deal to Buy Incremental COVID-19 Vaccines From Moderna And Pfizer-...
Via
Benzinga
Exposures
COVID-19
Mr. Market Will Shop ‘til He Drops!
December 01, 2021
Via
Talk Markets
How one mother is raising awareness for spinal muscular atrophy – a leading genetic cause of infant death
December 01, 2021
(BPT) - When Nicole Clark's son Brady was born, he was reaching his normal early milestones: holding his head up on his own, sitting and crawling. But when Nicole's energetic and seemingly healthy...
Via
Brandpoint
Exposures
Product Safety
7 Drug Stocks to Buy Now While They’re Still on Sale
November 30, 2021
Covid-19 stocks soared to unsustainable highs as investors ignored drug stocks with a deep pipeline of products for the decade ahead.
Via
InvestorPlace
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
Molecular Partners Says Its COVID-19 Antiviral Still Effective Against Positions Mutated In Omicron
November 30, 2021
Molecular Partners AG (NASDAQ: MOLN) said that its ensovibep, a tri-specific antiviral targeting the spike protein of SARS-CoV-2, maintains full potency against the...
Via
Benzinga
Exposures
COVID-19
3 Pharma Stocks That Are Too Cheap to Ignore
November 25, 2021
Many stocks are ridiculously expensive right now -- but not these three.
Via
The Motley Fool
Tuesday Markets Coverage
November 23, 2021
GE was up on hopes for cheaper oil. But most stocks were down on oil price hike fears.
Via
Talk Markets
Novartis May Have Buyer(s) For Its Sandoz Unit - Report
November 23, 2021
According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG...
Via
Benzinga
< Previous
1
2
...
18
19
20
21
22
23
24
25
26
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.